For the broader regulatory landscape, see our FDA-approved peptides list
It has emerged as a particularly relevant anti-inflammatory peptide due to an unusual property: oral bioavailability via the PepT1 intestinal transporter
Treatment for MS may include disease-modifying medications, symptom management medications, physical and occupational therapy, and complementary therapies such as acupuncture, massage therapy, and nutritional counseling
Immediate Benefits: Experience quicker results, such as increased energy, improved mood, and enhanced immune function
From thymosin alpha-1 and its capacity to rebalance T-cell populations, to KPV and its targeted anti-inflammatory action through NF-kB inhibition, to experimental peptides like P140/Lupuzor that have reached Phase III clinical trials specifically for lupus, the landscape of peptide-based immune modulation is expanding rapidly
No known interactions or contraindications